You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Plasma cells

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Immunophenotyping of Plasma Cells and Immune Effector Cells in

Not yet recruiting
  • Multiple Myeloma
  • Biological sampling
  • (no location specified)
Jun 17, 2022

Stratification in Multiple Myeloma Based on Fluorescence Flow

Recruiting
  • Myeloma Multiple
  • fluorescence flow cytometry
  • Saint Petersburg, Russian Federation
    Boris V Afanasyev, MD, Prof.
Jul 19, 2022

Healthy Trial in Rochester (5-13C-Glutamine, Bone marrow aspiration)

Recruiting
  • Healthy
  • 5-13C-Glutamine
  • Bone marrow aspiration
  • Rochester, Minnesota
    Mayo Clinic
Feb 10, 2022

Multiple Myeloma, Plasma Cell Leukemia Trial in Shanghai (Human BCMA targeted CAR-NK cells injection)

Recruiting
  • Multiple Myeloma
  • Plasma Cell Leukemia
  • Human BCMA targeted CAR-NK cells injection
  • Shanghai, Shanghai, China
    Shanghai Changzheng Hospital
Sep 13, 2023

Multiple Myeloma, Plasma Cell Leukemia Trial in Suzhou (CT0594CP)

Recruiting
  • Multiple Myeloma
  • Plasma Cell Leukemia
  • CT0594CP
  • Suzhou, Jiangsu, China
    First Affiliated Hospital, Soochow University
Apr 18, 2023

Relapsing Remitting Multiple Sclerosis, Primary Progressive Multiple Sclerosis, Secondary Progressive Multiple Sclerosis Trial

Recruiting
  • Relapsing Remitting Multiple Sclerosis
  • +2 more
  • Ixazomib (NINLARO®) capsules / Matching placebo capsules
  • London, Greater London, United Kingdom
    Royal London Hospital, Barts Health NHS Foundation Trust
Feb 17, 2022

Multiple Myeloma Cells From miRNAs Released From B Cells, and

Recruiting
  • Multiple Myeloma
    • Aviano, Pordenone, Italy
      Centro di Riferimento Oncologico (CRO) di Aviano - IRCCS
    Nov 23, 2023

    Relapsed and/or Refractory Multiple Myeloma, Plasma Cell Leukemia in Relapse Trial in Shanghai (Biological)

    Recruiting
    • Relapsed and/or Refractory Multiple Myeloma
    • Plasma Cell Leukemia in Relapse
    • Biological
    • Shanghai, Shanghai, China
      Shanghai Tongji Hospital
    May 29, 2023

    Multiple Myeloma in Remission Trial in Shenzhen, Haikou (MM-specific universal CAR T cells)

    Recruiting
    • Multiple Myeloma in Remission
    • MM-specific universal CAR T cells
    • Shenzhen, Guangdong, China
    • +1 more
    Aug 23, 2023

    Corneal Cells of Groth Factor-enriched Plasma and Autologous

    Recruiting
    • Aniridia
    • Peripheral venous blood sample
    • Conjunctival impression
    • Paris, France
      Hôpital Fondation A. de Rothschild
    Dec 6, 2022

    Multiple Myeloma Trial (BCMA-TGFß CAR-T cells (0.75 x10^6 cells/kg), BCMA-TGFß CAR-T cells (1 x 10^6 cells/kg), BCMA-TGFß CAR-T

    Not yet recruiting
    • Multiple Myeloma
    • BCMA-TGFβ CAR-T cells (0.75 x10^6 cells/kg)
    • +3 more
    • (no location specified)
    Jul 28, 2023

    Multiple Myeloma, Primary Plasma Cell Leukemia Trial in Shanghai (Experimental: CAR-T cells Infusion)

    Not yet recruiting
    • Multiple Myeloma
    • Primary Plasma Cell Leukemia
    • Experimental: CAR-T cells Infusion
    • Shanghai, China
      Shanghai Changzheng Hospital
    Apr 20, 2023

    Relapsed/Refractory Multiple Myeloma, Plasma Cell Leukemia Trial (CAR-T (CAR-GPRC5D))

    Not yet recruiting
    • Relapsed/Refractory Multiple Myeloma
    • Plasma Cell Leukemia
    • CAR-T (CAR-GPRC5D)
    • (no location specified)
    Feb 26, 2023

    Relapse/Refractory Multiple Myeloma Trial in Hangzhou (DeepTag-GPRC5D Targeted CAR T-cells)

    Recruiting
    • Relapse/Refractory Multiple Myeloma
    • DeepTag-GPRC5D Targeted CAR T-cells
    • Hangzhou, Zhejiang, China
      The first affiliated hospital of medical college of zhejiang uni
    Oct 10, 2023

    Thyroid Diseases, Hypothyroidism, Hashimoto Disease Trial in Tehran (curcumin, Anti-inflammatory diet)

    Not yet recruiting
    • Thyroid Diseases
    • +2 more
    • curcumin
    • Anti-inflammatory diet
    • Tehran, National Nutrition And Food Technology Research Institute, Iran, Islamic Republic of
      Golbon Sohrab
    Jul 27, 2023

    Multiple Myeloma, Immune System Diseases Trial in Chapel Hill (CAR138 T Cells)

    Recruiting
    • Multiple Myeloma
    • Immune System Diseases
    • CAR138 T Cells
    • Chapel Hill, North Carolina
      Lineberger Comprehensive Cancer Center at University of North Ca
    Jan 10, 2023

    Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Phoenix (Autologous MUC1-activated T-cells,

    Recruiting
    • Recurrent Plasma Cell Myeloma
    • Refractory Plasma Cell Myeloma
    • Phoenix, Arizona
      Mayo Clinic Hospital in Arizona
    Jan 4, 2023

    Multiple Myeloma Trial in Wuhan (Fludarabine + Cyclophosphamide + BCMA-GPRC5D CAR-T Cells)

    Recruiting
    • Multiple Myeloma
    • Fludarabine + Cyclophosphamide + BCMA-GPRC5D CAR-T Cells
    • Wuhan, Hubei, China
      Union Hospital, Tongji Medical College, Huazhong University of S
    Aug 11, 2023

    Thin Endometrium Trial in Moscow (Conservative therapy, PRP injection, Injection of PRP after conservative therapy)

    Completed
    • Thin Endometrium
    • Conservative therapy
    • +3 more
    • Moscow, Russian Federation
      Federal State Budget Institution Research Center for Obstetrics,
    Jul 8, 2022

    Perianal Fistula, Perianal Crohn Disease, Anal Fissure Trial in Winterthur (Regenerative therapy with SVF-PRP to supplement

    Not yet recruiting
    • Perianal Fistula
    • +4 more
    • Regenerative therapy with SVF-PRP to supplement perianal surgery
    • Winterthur, Switzerland
      Kantonsspital Winterthur
    Jan 24, 2023

    Stem Cells Mobilization, colLection and Engraftment in Newly

    Recruiting
    • Multiple Myeloma
    • +3 more
    • Rome, Italy
      Fondazione Policlinico Universitario A.Gemelli IRCCS
    Apr 28, 2023

    Multiple Myeloma Trial in Hangzhou (BCMA CAR-T cells injection)

    Recruiting
    • Multiple Myeloma
    • BCMA CAR-T cells injection
    • Hangzhou, Zhejiang, China
      The first affiliated hospital of medical college of zhejiang uni
    Feb 13, 2023

    Multiple Myeloma in Relapse, Multiple Myeloma, Refractory Trial (Anti-GPRC5D CAR-T Cells Injection)

    Not yet recruiting
    • Multiple Myeloma in Relapse
    • Multiple Myeloma, Refractory
    • Anti-GPRC5D CAR-T Cells Injection
    • (no location specified)
    Feb 18, 2023

    Apheresis to Obtain Plasma or White Blood Cells for Laboratory

    Recruiting
    • Healthy Volunteers
    • HIV
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Aug 18, 2022

      Myeloma Trial in Houston (Fludarabine phosphate, Cyclophosphamide, NY-ESO-1 TCR/IL-15 NK)

      Not yet recruiting
      • Myeloma
      • Fludarabine phosphate
      • +2 more
      • Houston, Texas
        M D Anderson Cancer Center
      Sep 27, 2023